Literature DB >> 6133069

Further experience of vitamin supplementation for prevention of neural tube defect recurrences.

R W Smithells, N C Nevin, M J Seller, S Sheppard, R Harris, A P Read, D W Fielding, S Walker, C J Schorah, J Wild.   

Abstract

In accordance with a previous protocol, a second cohort of 254 mothers with a history of previous neural tube defect (NTD) births was before a subsequent conception and continued until the time of the second missed menstrual period. There were 2 NTD recurrences (0.9% of 234 infants/fetuses examined), which is significantly fewer than the 11 NTD recurrences (5.1% of 215 infants/fetuses examined) born to 219 unsupplemented (US) mothers in the same centres over the same period. When the data for the two cohorts were combined, the overall recurrence rates were 0.7% for 454 fully supplemented (FS) mothers and 4.7% for 519 US mothers. The recurrence rates after 1 previous NTD were 0.5% for FS and 4.2% for US mothers: after 2 or more previous NTDs, 2.3% for FS and 9.6% for US. There were no recurrences among the offspring of a further 114 mothers whose duration of supplementation fell short of the full regimen (partially supplemented, PS).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133069     DOI: 10.1016/s0140-6736(83)92654-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  63 in total

1.  Fortification of flour with folic acid.

Authors:  B Wharton; I Booth
Journal:  BMJ       Date:  2001-11-24

2.  Public health 101 for informaticians.

Authors:  D Koo; P O'Carroll; M LaVenture
Journal:  J Am Med Inform Assoc       Date:  2001 Nov-Dec       Impact factor: 4.497

3.  With commentary.

Authors:  R W Smithells
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

4.  Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health.

Authors:  Scott D Grosse; Norman J Waitzman; Patrick S Romano; Joseph Mulinare
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

5.  Choosing a future for epidemiology: I. Eras and paradigms.

Authors:  M Susser; E Susser
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

6.  Folic acid fortification: what does it mean for patients and physicians?

Authors:  L A Turner; C McCourt
Journal:  CMAJ       Date:  1998-03-24       Impact factor: 8.262

7.  Targeted disruption of the methionine synthase gene in mice.

Authors:  D A Swanson; M L Liu; P J Baker; L Garrett; M Stitzel; J Wu; M Harris; R Banerjee; B Shane; L C Brody
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 8.  The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects.

Authors:  Anne M Molloy; Lawrence C Brody; James L Mills; John M Scott; Peadar N Kirke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

9.  The family history of uncomplicated congenital hydrocephalus: an epidemiological study based on 270 probands.

Authors:  J Lorber
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-04

10.  Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.

Authors:  Bridget S Mosley; Mario A Cleves; Anna Maria Siega-Riz; Gary M Shaw; Mark A Canfield; D Kim Waller; Martha M Werler; Charlotte A Hobbs
Journal:  Am J Epidemiol       Date:  2008-10-25       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.